ATE522816T1 - Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis - Google Patents

Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis

Info

Publication number
ATE522816T1
ATE522816T1 AT08863184T AT08863184T ATE522816T1 AT E522816 T1 ATE522816 T1 AT E522816T1 AT 08863184 T AT08863184 T AT 08863184T AT 08863184 T AT08863184 T AT 08863184T AT E522816 T1 ATE522816 T1 AT E522816T1
Authority
AT
Austria
Prior art keywords
naturally occurring
morphine
endogene
sepsis
marker
Prior art date
Application number
AT08863184T
Other languages
English (en)
Inventor
Yannick Goumon
Dominique Aunis
Marie-Helene Metz-Boutigue
Francis Schneider
Ingeborg Welters
Original Assignee
Inst Nat Sante Rech Med
Justus Liebig Uni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Justus Liebig Uni filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE522816T1 publication Critical patent/ATE522816T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08863184T 2007-12-18 2008-12-18 Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis ATE522816T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07301692 2007-12-18
PCT/EP2008/067907 WO2009077593A1 (en) 2007-12-18 2008-12-18 Endogenous morphine or a naturally occuring metabolite thereof as a marker for infection

Publications (1)

Publication Number Publication Date
ATE522816T1 true ATE522816T1 (de) 2011-09-15

Family

ID=39298209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08863184T ATE522816T1 (de) 2007-12-18 2008-12-18 Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis

Country Status (5)

Country Link
US (1) US20100304411A1 (de)
EP (1) EP2223122B1 (de)
AT (1) ATE522816T1 (de)
ES (1) ES2373009T3 (de)
WO (1) WO2009077593A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2717057A1 (de) 2012-10-04 2014-04-09 Cisbio Bioassays Morphin-6-glucuronid-Derivate, Immunogene und Immunassay
CN104101710B (zh) * 2014-04-02 2016-02-03 浙江省海洋开发研究院 一种海水鱼内生吗啡的检测方法及其检测试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500345A (en) * 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
US5272258A (en) * 1989-06-29 1993-12-21 Rush-Presbyterian-St. Luke's Medical Center Monoclonal antibodies to C-reactive protein
EP0722563A4 (de) * 1993-08-24 1998-03-04 Metrika Lab Inc Neues elektronisches einweg-assaygerät
FI20022048A0 (fi) * 2002-11-18 2002-11-18 Valtion Teknillinen Ei-kompetetiivinen immunomääritys pienille analyyteille

Also Published As

Publication number Publication date
EP2223122A1 (de) 2010-09-01
WO2009077593A1 (en) 2009-06-25
EP2223122B1 (de) 2011-08-31
US20100304411A1 (en) 2010-12-02
ES2373009T3 (es) 2012-01-30

Similar Documents

Publication Publication Date Title
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
PT2169387E (pt) Método multiparamétrico de alta sensibilidade para a análise de eventos raros numa amostra biológica
EP2419717A4 (de) Fluoreszenzsensor, fluoreszenzsensor in nadelform und analytmessverfahren
EP2464753A4 (de) Bioerkennungsverfahren und -zusammensetzungen
EP2448485A4 (de) Analytsensor
EP2047268A4 (de) Indikatorsystem zur bestimmung einer analytenkonzentration
ZA201403386B (en) A method of detecting and/or quantifying an analyte in a biological sample
EP3734274C0 (de) System zur messung viskoelastischer bluteigenschaften
PL1972275T3 (pl) Układ do pomiaru in vivo stężenia analitu
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
EP2167637A4 (de) Bioreaktorsondenverbindungssystem
FI20075439A0 (fi) Automatisoitu instrumentointi ja menetelmä näytteiden mittaamiseksi
EP2405264A4 (de) Biosensorensystem und vorrichtung zum messen einer analytkonzentration
EP2126556A4 (de) Elektrochemisches biosensormesssystem
BRPI0811453A2 (pt) Sistema de análise de amostra
JP2010048806A5 (ja) 流体内検体濃度検知システム
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
EP2350630A4 (de) Vorrichtung und verfahren für den nachweis eines analyts aus einer probe
DE112009003237A5 (de) Biopsie-instrument zur anreicherung von probenmaterial
EP2062052A4 (de) Verfahren zur bestimmung einer analytkonzentration
EP2169399A4 (de) Reagens zur messung einer bleikonzentration und verfahren zur messung einer bleikonzentration
EP2561350A4 (de) Verfahren und system zur analyse einer blutprobe
EP2545375A4 (de) Analytsensor und entsprechende verfahren
EP2347715A4 (de) Zerebrovaskuläres analysesystem
EP2104906A4 (de) System und verfahren zum analysieren von gewebeobjektträger zum wahrnemen von pathologien

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties